文献速递血栓与止血造血干细胞移植与细胞治疗

靶向血小板的基因治疗在血友病及其他疾病中诱导免疫耐受

Platelet-targeted gene therapy induces immune tolerance in hemophilia and beyond.
PubMed 文献 · J Thromb Haemost · 2023-08-07

本综述讨论靶向血小板的基因治疗,聚焦免疫耐受诱导。血友病临床前研究显示,通过慢病毒载体将基因递送至造血干细胞可实现治疗水平新蛋白表达、纠正出血表型并诱导抗原特异性免疫耐受;以卵清蛋白为替代蛋白的研究表明,该耐受通过外周克隆删除抗原特异性CD4和CD8效应T细胞及诱导抗原特异性调节性T细胞实现。

要点

  • 靶向血小板的基因治疗可在体内持续表达新蛋白,用于治疗疾病。
  • 血友病临床前研究显示慢病毒载体递送基因至造血干细胞可诱导抗原特异性免疫耐受。
  • 以卵清蛋白为替代蛋白的研究表明,免疫耐受通过删除抗原特异性CD4和CD8效应T细胞及诱导调节性T细胞实现。

核心结论

  • 靶向血小板的基因治疗在血友病临床前研究中显示出治疗水平新蛋白表达、纠正出血表型并诱导抗原特异性免疫耐受。

研究设计与样本

  • 综述,讨论靶向血小板的基因治疗,重点讨论免疫耐受诱导。

主要发现

  • 血友病临床前研究使用血小板特异性慢病毒基因递送至造血干细胞,获得治疗水平新蛋白表达,挽救出血表型并诱导抗原特异性免疫耐受。
  • 以卵清蛋白为替代蛋白的研究显示,通过外周克隆删除抗原特异性CD4和CD8效应T细胞及诱导抗原特异性调节性T细胞,诱导出强效抗原特异性免疫耐受。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Blood platelets have unique storage and delivery capabilities. Platelets play fundamental roles in hemostasis, inflammatory reactions, and immune responses. Beyond their functions, platelets have been used as a target for gene therapy. Platelet-targeted gene therapy aims to deliver a sustained expression of neo-protein in vivo by genetically modifying the target cells, resulting in a cure for the disease. Even though there has been substantial progress in the field of gene therapy, the potential development of immune responses to transgene products or vectors remains a significant concern. Of note, multiple preclinical studies using platelet-specific lentiviral gene delivery to hematopoietic stem cells in hemophilia have demonstrated promising results with therapeutic levels of neo-protein that rescue the hemorrhagic bleeding phenotype and induce antigen-specific immune tolerance. Further studies using ovalbumin as a surrogate protein for platelet gene therapy have shown robust antigen-specific immune tolerance induced via peripheral clonal deletions of antigen-specific CD4- and CD8-T effector cells and induction of antigen-specific regulatory T (Treg) cells. This review discusses platelet-targeted gene therapy, focusing on immune tolerance induction.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Kumar S, Schroeder JA, Shi Q, et al. Platelet-targeted gene therapy induces immune tolerance in hemophilia and beyond. J Thromb Haemost. 2023. PMID: 37558132. doi:10.1016/j.jtha.2023.07.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。